Sezary Syndrome Clinical Trials Sezary Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)
Conditions:   Cutaneous T Cell Lymphoma;   Mycosis Fungoides/Sezary Syndrome Interventions:   Drug: Pembrolizumab;   Radiation: Radiotherapy Sponsors:   University College, London;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2017 Category: Research Source Type: clinical trials